Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 926-932, February 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zachary, J. M.
Right arrow Articles by Lin, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zachary, J. M.
Right arrow Articles by Lin, S.

Actin Filament Organization of the Dunning R3327 Rat Prostatic Adenocarcinoma System: Correlation with Metastatic Potential1

J. Mark Zachary, Greg Cleveland, Lester Kwock2, Tommy Lawrence, Robert M. Weissman, Lisle Nabell, Floyd A. Fried, Edward V. Staab, Mary A. Risinger and Shin Lin

Department of Surgery, Division of Urology [J. M. Z., R. M. W., F. A. F.] and Department of Radiology [G. C., L. K., T. L., L. N., E. V. S.], University of North Carolina School of Medicine, Chapel Hill, North Carolina 27514; Department of Biophysics, The Johns Hopkins University, Baltimore, Maryland 21218 [M. A. R., S. L.]; and Department of Physics, University of North Carolina-Greensboro, Greensboro, North Carolina 27412 [G. C.]

Recently, Volk, Geiger, and Raz (Cancer Res., 44: 811–824, 1984) addressed the question of whether variations in actin organization in clones of the murine K-1735 melanoma tumor correlated with their metastatic capability. Using immunofluorescence techniques, they found that clones which had a more ordered actin network were less metastatic, whereas clones having a diffuse actin staining pattern were more metastatic. Similarly, we have found that in the Dunning rat R3327 prostatic adenocarcinoma tumor system, the non-metastatic (<0.1%) H-prostatic tumor cell line has a prominent network of actin filament bundles, whereas the highly metastatic (>90%) MatLyLu cell line has a diffuse actin staining pattern. In the low-metastatic (<10%) AT1 cell line an intermediate actin organization between H and MatLyLu was observed.

Analysis of cell extracts from H- and MatLyLu-cells revealed differences in the level of activity of cellular proteins which affect actin filament assembly and structure in a manner similar to that of the cytochalasins, fungal metabolites which bind with high affinity to the fast-growing end of actin filaments. Extracts of MatLyLu were significantly more effective than those of H-cells in decreasing the extent of actin filament network formation and in inhibiting the rate of filament assembly by blocking monomer addition onto the fast-growing end. Measurements of spin-lattice nuclear magnetic resonance water proton relaxation times (T1) were made in surgically removed tumor tissue from four sublines (H, AT1, MatLyLu, and MatLu) of the Dunning R3327 tumor system. The highly metastatic cell lines had significantly longer water proton T1 relaxation times than did the lines with low metastatic potential. These differences in T1 may reflect the observed alterations in organization of actin filaments within these various sublines of the Dunning R3327 prostatic adenocarcinoma tumor system.

1 This work was partially supported by research grants from the American Cancer Society (CD73 to S. L.) and the National Institutes of Health (GM-22289 to S. L. and CA-39633 to L. K.), by an institutional grant from the National Cancer Institute (CA 17973 to L. K.), and by a grant from the North Carolina Biotechnology Center (84-076 to L. K.).

2 To whom requests for reprints should be addressed.

Received 11/26/84. Revised 7/24/85. Revised 9/30/85. Accepted 10/29/85.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.